Caronia R M, Sturm R T, Fastenberg D M, Berke S J, Weintraub J
Department of Ophthalmology, Long Island Jewish Medical Center, USA.
Am J Ophthalmol. 1998 Aug;126(2):307-9. doi: 10.1016/s0002-9394(98)00101-9.
To describe bilateral hemorrhage of the posterior segment and secondary angle-closure glaucoma as sequelae of anticoagulation therapy in a nanophthalmic patient.
An 80-year-old man who was nanophthalmic and was undergoing anticoagulation therapy presented with declining visual acuity in left eye. Six months later, he experienced declining visual acuity in his right eye.
In the LE and six months later in the RE, ocular examination disclosed angle-closure glaucoma and a hemorrhagic retinal detachment. Peripheral iridoplasty successfully treated the initial attack. The subretinal hemorrhage was successfully drained by pars plana vitrectomy, retinotomy, and air-fluid exchange in the left eye. Anatomic success and intraocular pressure control were obtained, but visual recovery was limited.
Intraocular hemorrhage and angle-closure glaucoma are potential complications of anticoagulation therapy in a patient with nanophthalmos.
描述一例小眼球患者抗凝治疗后出现的双侧眼后段出血及继发性闭角型青光眼后遗症。
一名80岁小眼球且正在接受抗凝治疗的男性患者，左眼视力下降。6个月后，右眼视力也下降。
左眼及6个月后的右眼，眼科检查发现闭角型青光眼和出血性视网膜脱离。周边虹膜成形术成功治疗了初次发作。左眼通过玻璃体切割术、视网膜切开术和气液交换成功引流了视网膜下出血。获得了解剖学成功和眼压控制，但视力恢复有限。
小眼球患者抗凝治疗可能出现眼内出血和闭角型青光眼等并发症。
